Introduction
This review was conducted by scanning PubMed for articles on burns and thermal injuries published during the years 2006 and 2007. The author then subjectively selected those articles that would be of interest to intensivists who may care for burn patients.
Transfusion
Palmieri et al.
[1 ] reviewed transfusion practices in 666 patients with burns involving more than 20% of total body surface area (TBSA) from 21 burn centers. Patients received nearly 14 units of blood each; the mean hemoglobin concentration at the time of first transfusion was about 9 g/dl. Each unit of blood increased the risk for infection by 13%, and mortality increased with the number of units of blood transfused.
Burn surgeons are evolving slowly toward adopting a restrictive transfusion trigger of hemoglobin concentration of 7 g/dl, as introduced in 1999 in a study conducted by Hebert et al. [2] . Kwan et al.
[3 ] adopted a restrictive transfusion policy for burns in 1999. Outcomes in patients managed with a transfusion trigger of 7 g/dl were compared with those in historical control individuals. Mean hemoglobin concentrations before transfusion were 9.2 g/dl (control) and 7.1 g/dl (restrictive). Mean daily hemoglobin concentrations were 10.2 g/dl (control) and 8.6 g/dl (restrictive). The restrictive group received fewer blood transfusions per day (0.4 AE 0.4 units versus 0.6 AE 0.6 units; P ¼ 0.03), had a better organ dysfunction score, and had a lower mortality rate (19% versus 38%; P ¼ 0.03). These findings suggest that a restrictive transfusion policy should be adopted in burns.
Compartment syndromes
Oda et al. [4 ,5 ] reported two papers on abdominal compartment syndrome (ACS) in burns in 2006. In one report [4 ], eight out of 48 patients with a mean TBSA burned of 45.9% AE 21.8% developed ACS. All patients with ACS received resuscitation volumes of 300 ml/kg per 24 h or greater. The other report [5 ] compared hypertonic resuscitation with 'Parkland' resuscitation in terms of decreasing the risk for ACS. The hypertonic group maintained adequate urine output with lower volumes of resuscitation and had a lower incidence of intra-abdominal hypertension (2/14 versus 11/22). As in their other report, the critical volume associated with development of intra-abdominal hypertension was approximately 300 ml/kg per 24 h. This number is a pearl that should be taken away by the readers of these papers for use in their clinical practice.
Jensen et al. [6] reported on four cases of secondary ACS in children. One patient was treated successfully with percutaneous decompression. This adds to the experience of others [7, 8, 9 ] in percutaneous decompression. Although there is enthusiasm for this technique, it must be applied judiciously. Elevated pressures can recur after percutaneous drainage if bowel edema develops.
Endocrine
[10 ] examined function of the hypothalamic-pituitary-adrenal axis in children with burns over more than 20% of TBSA. All patients met the definition of adrenal insufficiency, as described by the Surviving Sepsis Campaign [11] , but none of the patients received exogenous steroids, and mortality was not affected by total serum cortisol concentrations. The role of exogenous steroids in the treatment of adrenal insufficiency in burned children requires further study.
Monitoring of resuscitation
Kuwa et al. [12 ] evaluated the utility of power Doppler ultrasound in measuring renal perfusion. They found that power Doppler ultrasound image intensity correlated better with directly measured renal cortical microvascular blood flow than did urine output in a burned swine model. Arlati et al. [13 ] conducted a study to compare a noninvasive intrathoracic blood volume-guided and cardiac output-guided approach to resuscitation with a 'Parkland' formula. They achieved resuscitation with less fluid administered, less edema formation, and lower organ dysfunction scores using the former. Most noteworthy is the appearance of the term 'permissive hypovolemia'. Burn physicians are evolving their practice to avoid the negative consequences of over-resuscitation. Eventually, there will be more sensitive markers of organ perfusion than urine output.
Technology
Hoskins et al. [14 ] automated resuscitation volume based on hourly urine output. The technology consisted of a personal computer, an infusion pump, and a urine flow meter. Automation led to less hourly variation in infusion rate and urine output, and was under the target for urine output less often than was technician-directed resuscitation. This technology is a logical advance in guiding burn resuscitation.
Myocardial inflammation
Horton et al. [15, 16 ] reported two papers in 2006 describing the effects of burn treatment on myocardial inflammation. One experiment [15] showed that hypertonic saline-dextran resuscitation reduced myocardial inflammation associated with a 'second hit'. The other study [16 ] examined the effect of immediate burn excision and grafting (30 min after burn) on myocardial inflammation in a rat model. Decreased contractility and relaxation, as well as expression of inflammatory cytokines, could be abrogated by immediate excision and grafting. This supports the modern practice of early excision and grafting. Optimal timing of early excision and grafting is unclear, but if it can be conducted safely then immediate excision and grafting may spare patients the inflammatory storm and painful nonoperative management that occurs until the time of eventual excision and grafting.
Airway
Khan et al. [17 ] described a technique for securing the airway in cases of microstomia secondary to burn contracture. By introducing a stylet into a laryngeal mask airway and lubricating the apparatus generously, it could be inserted into the oral cavity in an upside-down manner (as when inserting an oropharyngeal airway), and rotated 1808 into the proper orientation.
Models of smoke inhalation
Several reports on the ovine model of cotton smoke inhalation appeared in the review period. Wang et al. [18] compared high-frequency percussive ventilation with volume-controlled mechanical ventilation, both with adjunctive heparin. The heparinization was based on previous work showing improved oxygenation and clearance of tracheobronchial casts with systemic heparin. Percussive ventilation decreased mortality by 50%. Morita et al. [19] reported on use of nebulized vitamin E, and found that it reduced capillary leak in the lung, decreased shunt fraction, improved arterial oxygen tension (PaO 2 ) : fractional inspired oxygen (FiO 2 ) ratio, and decreased generation of reactive nitrogen species. Maybauer et al. [20] reported on use of recombinant human activated protein C (rhAPC) in the treatment of the ovine model, with airway instillation of bacteria to simulate clinical inhalation injury. They postulated that the anticoagulant and anti-inflammatory properties of rhAPC may improve the response to smoke inhalation. At various time points, rhAPC improved the PaO 2 : FiO 2 ratio and decreased pulmonary microvascular shunt fraction. No bleeding complications were observed. Although interesting and of potential future importance in clinical care, use in humans for this indication would be premature. The final report in the ovine model is that by Palmieri et al. [21] on use of continuous nebulized albuterol. Treated animals had lower airway pressures, less lung water accumulation, and higher PaO 2 : FiO 2 ratio. In an accompanying editorial, Wiener-Kronish and Matthay [22] reported that the Acute Respiratory Distress Syndrome Network is planning a prospective, randomized, multicenter trial of this intervention. The risks for tachycardia and electrolyte disturbance should keep clinicians from adopting continuous nebulized albuterol until research in humans is available.
Huang et al. [23] , in a rat wood smoke model of smoke inhalation, studied hypothermia for protection against acute lung injury. Hypothermic rats exhibited less lipid peroxidation and inflammatory cytokine expression than did normothermic rats. It is not clear how to apply clinically any of the information derived from animal smoke inhalation models. How is the clinician to know whether wood smoke or cotton smoke in sheep or rat approximates to burning house smoke in humans? At present, it would be premature to apply these interventions clinically to protect against smoke-induced acute lung injury.
Endotracheal tubes
Sheridan [24 ] suggested that the dogma of using uncuffed endotracheal tubes in children is ill-advised if more than transient intubation is needed. Five children required emergent reintubation over a 5-year period because of massive air leak from uncuffed tubes. This can be avoided by using cuffed endotracheal tubes in seriously burned children. The risks associated with an appropriately inflated cuff appear to be lower than the risk for inadvertent extubation in the massively swollen child.
Infection
Chen et al. [25] showed that hypertonic resuscitation in a burned mouse model decreased bacterial translocation by increasing phagocytic activity of peritoneal and systemic inflammatory cells. This report may not yet be applicable at the bedside, but it should serve to remind clinicians that the effects of our interventions are not all apparent on rounds or in the clinical laboratory.
Kiser et al. [26 ] showed once again that pharmacokinetics and pharmacodynamics are unpredictable in major burns. They evaluated 11 patients with burns over more than 30% of TBSA and normal renal function who received levofloxacin for clinical indications. By Monte Carlo simulation, the investigators attempted to determine how often target concentrations would be achieved. For organisms with minimum inhibitory concentrations (MICs) of 1 mg/ml or greater, including those difficult organisms whose MICs are 2 mg/ml (levofloxacin's approved susceptibility breakpoint), target concentrations would not be achieved reliably. Therefore, even though the laboratory may report an organism to be susceptible, it is likely that the necessary antibiotic concentration will not be achieved for organisms with high MICs. This cautions against the use of levofloxacin 750 mg once daily for empiric therapy of serious infections in burn patients.
Conil et al. [27 ] examined dosing of amikacin in burns. They had previously shown that a once daily dosing regimen of 15 mg/kg per day led to maximal concentration : MIC ratio of greater than 6 in only 13% of cases. To achieve the desired maximal concentration : MIC ratio doses of 25-30 mg/kg per day may be needed, with therapeutic drug level monitoring, particularly in patients with burns over more than 15% of TBSA. Although aminoglycosides have fallen from favor, they still have a role to play when pharmacokinetics and pharmacodynamics are unpredictable.
Selective digestive decontamination
de La Cal et al. [28] reported a prospective, randomized, placebo-controlled, double-blind trial of selective digestive decontamination (SDD) in burns over more than 20% of TBSA. The intervention consisted of intravenous cefotaxime for 4 days, and oropharyngeal and enteral administration of polymyxin E, tobramycin, and amphotericin B. There was an adjusted risk ratio for mortality of 0.28 (95% confidence interval 0.10 to 0.80), and fewer patients developed infection (43% versus 74%; P ¼ 0.01), favoring SDD. This trial showed a reduction in mortality, but SDD has not been adopted as a standard of care. Why is this? Eggimann et al. [29 ] have questioned the timing of the deaths in the study. There were five deaths in the SDD group and 15 in the placebo group, 11 of which occurred during the first 2 weeks. Although infections may manifest after the first week, deaths from those infections would be expected later in the course. If the 11 deaths in the placebo group during the first 2 weeks are eliminated, then the mortality difference is lost. Despite the randomized controlled trial being well designed and conducted, the timing of the deaths leaves the issue in question.
Energy expenditure
Suman et al. [30 ] performed a comparison of predicted resting energy expenditure (REE) against measured REE in burned children. Predictions all underestimated caloric needs measured by indirect calorimetry; measured REE was 152% of predicted for all three formulae used, including the Harris-Benedict equation. The authors recommended that indirect calorimetry be used for severely burned children.
Mlcak et al.
[31 ] examined 100 children with burns over more than 40% of TBSA prospectively to determine age and sex differences in REE. The most interesting finding, in the writer's opinion, is that infants and toddlers do not exhibit a hypermetabolic response at all. The second finding, which comprises the bulk of the report, is that males exhibit a greater increase in REE than do females. This has implications for the nutritional management of children and emphasizes the Advances in burn care Namias 407 use of indirect calorimetry, as opposed to predictive equations. In centers in which indirect calorimetry is available, it should be used. In centers where it is not available, its adoption should be considered.
Oxandrolone
Przkora et al.
[32 ] performed a prospective, randomized trial of oxandrolone with and without exercise in children with burns over more than 40% of TBSA. Oxandrolone, along with resistance training and aerobic exercise, increased weight and lean body mass compared with not receiving the combined interventions. Wolf et al.
[33 ] showed that oxandrolone, 10 mg twice daily, decreased length of stay by 28% for patients with burns between 20% and 60% of TBSA. This was a well designed and conducted trial. It had a clear objective and equally clear results. Adults with burns over more than 20% of TBSA should receive oxandrolone 10 mg twice daily from the time that they can receive enteral alimentation until the time of hospital discharge. Adverse events were minor. The authors expressed considerable concern over the potential for hepatic toxicity, but they did not find any difference in transaminase concentrations between groups. In fact, McCullough et al. [34] recently reported a case-control series of patients with major burns who received oxandrolone, which they conducted specifically to examine hepatic toxicity. They found no difference in the incidence of hepatic toxicity.
Wound healing
Galeano et al. [35 ] studied the effect of recombinant human erythropoietin on wound healing in a mouse burn model. After scalding, the animals were randomly assigned to recombinant human erythropoietin or placebo for 14 days. Animals receiving active drug had faster re-epithelialization, increased angiogenesis, and increased wound content of vascular endothelial growth factor. The known risks associated with this intervention mandate that trials in humans be performed before it is adopted clinically for this indication.
Thromboembolism
A review conducted by the French Society for Anesthesia and Critical Care [36 ] showed that the risk for deep venous thrombosis following burn injury ranges from 0.9% to 3%, and that the risk for pulmonary embolus ranges from 0.4% to 1.2%. Recommendations for prophylaxis are summarized in Table 1 . External compression should be used in concert with chemoprophylaxis whenever possible. Note that the grade of recommendation for all recommendations is D: 'agreement among professionals'. This is an unacceptable state of our science and must be addressed in well designed trials.
Recombinant factor VIIa
Johansson et al. [37] described use of recombinant factor VIIa in four patients who developed profuse, life-threatening microvascular bleeding after excision of a mean of 55% TBSA full thickness burn. Bleeding was controlled within 15 min with a 100 mg/kg bolus of recombinant factor VIIa. There were no thromboembolic complications. Recombinant factor VIIa should be reserved for situations in which conventional techniques have been exhausted. Indiscriminate use of this agent should be avoided.
Sex differences
Kerby et al. [38] reviewed nearly 35 000 men and 15 000 women entered into the American Burn Association National Burn Repository for sex differences. Women had a 30% greater likelihood of mortality after adjusting for age, race, TBSA burn, and inhalation injury. This sex difference only held true in patients between the ages of 10 and 70 years, which led the authors to speculate that it is due to the immunomodulatory effects of estrogen. With such a large magnitude of difference, prospective studies of outcome in smaller groups could be performed.
Conclusion
The application of the scientific method to burn care is improving slowly. Randomized controlled trials are Note that all recommendations are based only on expert opinion. This is an unacceptable state of the science. ECS, elastic compression stockings; LMWH, low-molecular-weight heparin; TBSA, total body surface area; UFH, unfractionated heparin. Adapted from Samama et al. [35 ] .
becoming more common. There is a need for translation of excellent animal work to the human arena.
